Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Ontada Study: Hemoglobin >10 g/dL Boosts Survival in MDS
Ontada, a McKesson business dedicated to real-world oncology insights, will present results from a retrospective cohort study at the 67th American Society of Hematology Annual Meeting. The study, titled “Maintaining Higher Hemoglobin Levels is Associated with Improved Overall Survival in Myelodysplastic Syndromes: A Real-world Retrospective Analysis of Electronic Health Records from a US Community Setting Over 20 Years,” examines how sustained hemoglobin levels affect survival in patients with myelodysplastic syndromes. Using structured electronic health record data from U.S. community practices spanning two decades, the analysis provides a detailed view of anemia management and its long-term outcomes in patients with MDS.
AOM Infusion Named Limited-Distribution Partner for YIMMUGO
AOM Infusion, known nationally for its specialty infusion and pharmacy services that support people managing chronic and complex medical needs, has been selected by Kedrion Biopharma to join the limited distribution network for YIMMUGO (Immune Globulin Intravenous, Human-dira, 10%). This addition strengthens AOM’s portfolio of IVIG therapies and expands access to an important treatment option for patients with primary humoral immunodeficiency (PI).
IQVIA, AWS Partner on Next-Gen AI Health Platform
IQVIA, a global leader in clinical research, real-world insights and healthcare intelligence, announced a major new partnership with Amazon Web Services as it names AWS its Preferred Agentic Cloud Provider. The collaboration, unveiled during AWS re:Invent, marks a significant step in the ongoing modernization of the life sciences and healthcare sectors as IQVIA prepares to build and scale its next generation agentic AI platform through AWS infrastructure.
Bayer Launches Phase III Mirena Study for Endometrial Hyperplasia
Bayer has announced the initiation of the Phase III SUNFLOWER study, designed to assess the safety and effectiveness of the 52mg levonorgestrel-releasing intrauterine system Mirena for treating nonatypical endometrial hyperplasia in women. Nonatypical endometrial hyperplasia is a condition where the lining of the uterus becomes abnormally thick due to an imbalance of estrogen and progesterone. The cells in this condition do not show cancerous changes, but women may experience heavy, irregular, or postmenopausal bleeding, and if left untreated, the condition can increase the risk of uterine cancer. Approximately 121 women per 100,000 develop NAEH each year, and currently, there are no approved medical treatments available, creating a significant unmet need.
Elevance Health Enhances Care with Personalization and Service
Saurabh Tandon, Chief Experience Officer at Elevance Health, discussed how the company is reimagining healthcare by learning from consumer-focused industries such as streaming services and creating a more personalized experience for each member. He explained that the future of healthcare involves anticipating consumer needs, addressing issues promptly, and building long-term relationships. Unlike entertainment, healthcare requires an even deeper level of personalization because it is highly personal and trust is essential. Elevance Health earns that trust by providing convenient, flexible support through mobile chat, seamless claim management, easier provider searches, and simplified billing and prescription services while keeping data secure.
To share your insights, please write to us at sudipto@intentamplify.com
